Osteoporosis in childhood and adolescence;Osteoporose na infância e na adolescência

Jornal de Pediatria

Volumn 79, Issue 6, 2003, Pages 481-488

  Campos, Lúcia M A ^a,b   Liphaus, Bernadete L ^a   Silva, Clóvis A A ^a   Pereira, Rosa M R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital das Clinicas da FMUSP ^*  (Brazil)

Author keywords

Adolescents; Children; Osteoporosis

Indexed keywords

CALCITONIN; SALCATONIN;

ADOLESCENT; BONE METABOLISM; CHILD; CHILDHOOD DISEASE; DIAGNOSTIC IMAGING; HUMAN; LABORATORY DIAGNOSIS; MEDLINE; OSTEOPENIA; OSTEOPOROSIS; PATIENT COUNSELING; REVIEW; RISK ASSESSMENT;

EID: 1642542463     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-75572003000600005     Document Type: Review

References (35)

1. NIH Consensus Statement, n. 111, Osteoporosis prevention, diagnosis and therapy. 2000;17:1-36.
2. Rigss BL, Melton LJ, The worldwide problem of osteoporosis: insight afforded by epidemiology. Bone. 1995;17(5 Suppl): S505-11.
3. Van der sluis IM, Muinck Keizer-Schrama SMPF. Osteoporosis in childhood: bone density in children in health and disease, J Pediatr Endocrinol Metab. 2001;14:817-32.
4. The WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, Switzerland: World Health Organization; 1994.
5. Zerbini CAF. Osteoporose: uma revisão. Jovem Médico. 1998;2:89-94.
6. Cassidy JT. Osteopenia and osteoporosis in children. Clin Exp Rheumatol. 1999;17:245-50.
7. McDonagh JE. Osteoporosis injuvenile idiopathic arthritis. Curr Opin Rheumatol. 2001;13:399-404.
8. a ed. São Paulo: Savier; 2002. p. 354-62.
9. Golding A, Jones IE, Taylor RW, Manning PJ, Williams SM. More broken bones: a four-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res. 2000;15:2011-18.
10. Pereira RMR, Corrente JE, Chahade WH, Yoshinari NH. Evaluation by dual X-ray absorptiomotry (DXA) of bone mineral density in children with juvenile chronic arthritis. Clin Exp Rheumatol. 1998;16:495-501.
11. Lu PW, Cowell CT, Lloyd-Jones AS, Briody JN, Howman-Giles R. Volumetric bone mineral density in normal subjects, aged 5-27 years. J Clin Endocrinol Metab. 1998;83:1420-27.
12. Kroger H, Kotaniemi A, Vaino P, Alhava E. Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Mineral. 1992;17:75-85.
13. Molgaard C, Thomsen BL, Michaelsen KF. Influence of weight, age and puberty on bone size and bone mineral content in healthy children and adolescents. Acta Paediatr. 1998;87:494-9.
14. Pereira RMR, Falco V, Corrente JE, Chahade WH, Yoshinari NH. Abnormalities in the biochemical markers of bone turnover in children with juvenile chronic arthritis. Clin Exp Rheumatol. 1999;17:251-5.
15. Mora S, Pitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V. Biochemical markers of bone turnover and the volume and the density of bone children at different stages of sexual development. J Bone Miner Res. 1999;14:1664-71.
16. Swaminathan R. Biochemical markers of bone turnover. Clin Chim Acta. 2001;313:95-105.
17. a ed. San Diego: Academic Press; 2001, p. 459-77.
18. Saggese G, Baroncelli GI, Bertelloni S, Osteoporosis in children and adolescents: diagnosis, risk factors and prevention. J Pediatr Endocrinol Metab. 2001;14:833-59.
19. Pereira RMR. Osteoporose juvenil, Acta Fisiátrica. 1997;2: S135-8.
20. Horowitz, MC, Cytokines and estrogen in bone: anti-porotic effects. Science. 1993;260:626-7,
21. a ed. Rio de Janeiro: Revinter; 2001, p. 409-13.
22. Castro TC, Terreri MT, Szejnfeld VL, Castro CH, Fisberg M, Gabay M, et al. Bone mineral density injuvenile systemic lupus erythematosus. Braz J Med Biol Res. 2002;35:1159-63.
23. Rubin K, Schirduan V, Gendreau P, Sarfarazi M, Mendola R, Dalsky G. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. J Pediatr. 1993;123:863-70.
24. Moretto PA, Contribuição ao estudo da osteoporose em crianças e adolescentes portadores de lúpus eritematoso sistêmico [dissertação de mestrado]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 1996.
25. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK Consensus group on management of glucocorticoid-induced osteoporosis: an update. J Int Med. 1998;244:271-92.
26. Boulos P, Adachi JD, Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol. 2000;18:S79-86.
27. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocoritcoid-Induced Osteoporosis. Arthritis Rheum. 2001;44:1496-503.
28. Szejnfeld VL. Atualização terapêutica em osteoporose. Rheuma. 1995;2:4-7.
29. Pinto Neto AM, Soares A, Urbanetz AA, Souza ACA, Ferrari AEM, Amaral B, et al. Consenso brasileiro de osteoporose 2002. Rev Bras Reumatol. 2002;42:343-54.
30. Nutritive Value of Foods. Home and Garden Bulletin. US Department of Agriculture. Washington, DC: US Government Printing Office; 1988.
31. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone on fractures and bone mineral density in postmenopausal women with osteoporosis. N Eng J Med. 2001;344(19):1434-41.
32. Brumsen C, Hamdy NAT, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine. 1997;76:266-83.
33. Roux C, Dougados M. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol. 2000;18:S49-52.
34. Allgrove J. Use of bisphosphonate in children and adolescents. J Pediatr Endocrinol Metab. 2002; 15 Suppl 3:921-8.
35. Chestnut CH III, Silverman S, Adriano K, Genant HK, Gimona A, Harris S, A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent recurrence of Osteoporotic Fractures Study. Am J Med. 2000;109:267-76.